BNP PARIBAS ARBITRAGE, SA
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1166588
NEW YORK, NY
Position in XERS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,524,164
-$504,024 QoQ
Shares Held
262,787
+1.7% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $498,843,244 across 54 Drug Manufacturers - Specialty & Generic names. XERS ranks #26 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,049,626 | $124,076,289 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
3,183,971 | $44,097,998 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
62,008 | $36,769,503 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
647,731 | $31,188,247 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
233,500 | $30,761,290 | |
| 6 | VTRS |
Viatris Inc
|
2,095,093 | $28,304,706 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,111,137 | $26,589,508 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
877,568 | $26,432,348 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,524,164 | 262,787 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,028,188 | 258,368 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,735,192 | 581,719 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $76,167 | 16,310 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,893,435 | 344,888 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $339,040 | 100,012 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||